← All companies

BridgeBio

Healthcare & Life Sci

Company overview

BridgeBio develops medicines for rare genetic conditions. Attruby, also known as acoramidis, is one of its FDA-approved medicines. NULIBRY, also known as fosdenopterin, is another FDA-approved medicine from the company. In total, the company has received 3 FDA approvals for its medicines.

BridgeBio has more than 2,000 patients enrolled in its clinical trials around the world. BridgeBio is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
San Francisco, United States

Filters

Create your account

Create an account to save jobs and track applications.